When did Viatris report Q4 2025 earnings?

Viatris (VTRS) reported Q4 2025 earnings on February 26, 2026 before market open.

What were Viatris's Q4 2025 revenue and EPS?

Viatris reported revenue of $3.7B and diluted EPS of $0.57 for Q4 2025.

Did Viatris beat estimates in Q4 2025?

Revenue beat the consensus estimate of $3.5B by $171.3M. EPS beat the consensus estimate of $0.53 by $0.04.

How did Viatris's Q4 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 5.0% from $3.5B a year earlier and diluted EPS grew 5.6% from $0.54.

Where can I find Viatris's Q4 2025 SEC filings?

You can read the 8-K earnings release (0001792044-26-000010) and the 10-K periodic report (0001792044-26-000013) directly on SEC EDGAR. The filing index links above go to sec.gov.

Viatris VTRS Q4 2025 Annual earnings

Reported February 26, 2026 · Before market open

Revenue$3.7BBeat by $171.3M Diluted EPS$0.57Beat by $0.04

Revenue estimate$3.5B

EPS estimate$0.53

Next report

Aug 6, 2026 (In 3 weeks)

Revenue estimate$3.7B

EPS estimate$0.62

Financials

Q4 2025

Income statement

See full

Revenue$3.7B+5.0%

Gross profit$1.1B-5.5%

Operating income-$192.7M—

Net income-$340.1M+34.2%

EPS (diluted)-$0.30+30.2%

Balance sheet

See full

Cash & equivalents$1.3B+83.1%

Total debt$14.7B+2.7%

Total equity$14.7B-21.1%

Total assets$37.2B-10.4%

Cash flow

See full

Operating cash flow$815.8M+69.0%

CapEx$196.5M+40.0%

Free cash flow$619.3M+80.9%

Valuation & ratios

Valuation

as of 12/31/25

See full

Market cap$14.34B-3.5%

Enterprise value$27.69B-2.6%

P/S1×0.0×

Profitability

See full

Gross margin35.1%-3.1pp

Operating margin-18.6%—

Net margin-24.6%-31.2pp

FCF margin13.5%+0.1pp

Returns & leverage

See full

Return on equity-21.1%-25.8pp

Debt / equity1×+0.2×

Current ratio1.4×-0.3×

Segments

By product

See full

Lipitor$377.3M+6.0%

Norvasc$175.2M+5.4%

Lyrica ®$119.8M-5.7%

Viagra ®$104.2M+17.6%

Creon ®$98.9M+9.4%

By segment

See full

Greater China$572.9M+9.7%

Emerging Markets Segment$565.8M+10.1%

Japan, Australia and New Zealand Segment$306.6M-8.8%

Versus estimates

Revenue

Q1 2026$3.5BBeat by $160.0M

Q4 2025$3.7BBeat by $171.3M

Q3 2025$3.8BBeat by $136.2M Q2 2025$3.6BBeat by $115.1M Q1 2025$3.3BBeat by $19.0M Q4 2024$3.5BMiss by $71.9M

Diluted EPS

Q1 2026$0.59Beat by $0.07

Q4 2025$0.57Beat by $0.04

Q3 2025$0.67Beat by $0.05 Q2 2025$0.62Beat by $0.06 Q1 2025$0.50Beat by $0.01 Q4 2024$0.54Miss by $0.07

Ask the moment Viatris reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Viatris report Q4 2025 earnings?: Viatris (VTRS) reported Q4 2025 earnings on February 26, 2026 before market open.
What were Viatris's Q4 2025 revenue and EPS?: Viatris reported revenue of $3.7B and diluted EPS of $0.57 for Q4 2025.
Did Viatris beat estimates in Q4 2025?: Revenue beat the consensus estimate of $3.5B by $171.3M. EPS beat the consensus estimate of $0.53 by $0.04.
How did Viatris's Q4 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 5.0% from $3.5B a year earlier and diluted EPS grew 5.6% from $0.54.
Where can I find Viatris's Q4 2025 SEC filings?: You can read the 8-K earnings release (0001792044-26-000010) and the 10-K periodic report (0001792044-26-000013) directly on SEC EDGAR. The filing index links above go to sec.gov.